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During host infection, Pseudomonas aeruginosa coordinately regulates the expression
of numerous genes to adapt to the host environment while counteracting host clearance
mechanisms. As infected patients take antibiotics, the invading bacteria encounter
antibiotics in the host milieu. P. aeruginosa is highly resistant to antibiotics due to
multiple chromosomally encoded resistant determinants. And numerous in vitro studies
have demonstrated the regulatory mechanisms of antibiotic resistance related genes
in response to antibiotics. However, it is not well-known how host environment affects
bacterial response to antibiotics. In this study, we found that P. aeruginosa cells directly
isolated from mice lungs displayed higher susceptibility to tobramycin than in vitro
cultured bacteria. In vitro experiments demonstrated that incubation with A549 and
differentiated HL60 (dHL60) cells sensitized P. aeruginosa to tobramycin. Further studies
revealed that reactive oxygen species produced by the host cells contributed to the
increased bacterial susceptibility. At the same concentration of tobramycin, presence
of A549 and dHL60 cells resulted in higher expression of heat shock proteins, which
are known inducible by tobramycin. Further analyses revealed decreased membrane
potential upon incubation with the host cells and modification of lipopolysaccharide,
which contributed to the increased susceptibility to tobramycin. Therefore, our results
demonstrate that contact with host cells increased bacterial susceptibility to tobramycin.
Keywords: infection, Pseudomonas aeruginosa, host cells, tobramycin, neutrophil, membrane potential
INTRODUCTION
Pseudomonas aeruginosa is an opportunistic bacterial pathogen which causes acute and chronic
infections in human. It is one of the major pathogens causing nosocomial infections (Driscoll et al.,
2007; De and Plésiat, 2011). P. aeruginosa possesses multiple antibiotic resistance mechanisms,
such as lowmembrane permeability, antibiotic inactivating enzymes, multidrug eﬄux systems, and
biofilm formation (Morita et al., 2014).
Genes involved in antibiotic resistance are tightly controlled by various regulatory pathways
in response to antibiotic induced stresses (Poole, 2011). For example, β-lactam antibiotics inhibit
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peptidoglycan crosslink, leading to aberrant accumulation of
muropeptides in cytoplasm, which activates AmpR, a LysR-type
transcriptional regulator. Upon activation, it directly up regulates
the expression of a chromosomally encoded β-lactamase AmpC,
thus enhancing bacterial resistance to β-lactam antibiotics (Kong
et al., 2005). Aminoglycoside antibiotics inhibit translation.
Stalling of ribosome in the leader peptide of PA5471.1 activates
the transcription of downstream gene (PA5471) through a
transcription attenuation mechanism (Morita et al., 2009). The
PA5471 protein binds to MexZ, releasing it from the promoter of
mexX-mexY genes, which encode an eﬄux pump that is mainly
responsible for bacterial resistance against aminoglycoside
antibiotics (Morita et al., 2012a,b). In addition, it has been
demonstrated that sub-inhibitory concentrations of tobramycin,
ciprofloxacin, or tetracycline enhanced P. aeruginosa biofilm
formation (Hoffman et al., 2005; Linares et al., 2006).
Similar to antibiotics, host environment also imposes stresses
to the invading bacteria, such as antimicrobial peptides, low
iron environment, reactive oxygen species (ROS) generated by
phagocytes. In response, bacteria orchestrate the production
of a variety of virulence factors to counteract host defense
mechanisms (Lyczak et al., 2000). Upon contact with host
cells, the type III secretion system (T3SS) of P. aeruginosa is
activated, which injects effector proteins into host cells, causing
alteration of cell signaling or cell death (Hauser, 2009). It
has been demonstrated in a murine acute pneumonia model
that P. aeruginosa preferentially injects T3SS effector proteins
into neutrophils (Geddes et al., 2008; Berube et al., 2016).
Expression of the T3SS is regulated by multiple regulatory
pathways. Small RNAs RsmY and RsmZ reciprocally regulate
T3SS and biofilm formation (Gooderham and Hancock, 2009).
The alginate regulatory factor AlgU negatively regulates T3SS
(Intile et al., 2014). And the cAMP receptor protein Vfr activates
the expression of T3SS genes. In addition, Vfr is required for
flagellum, pilus biosynthesis, type II secretion system, and the
expression of exotoxin A. Exotoxin A is also under the regulation
of PvdS (Ochsner and Vasil, 1996). In response to the host low
iron environment, PvdS activates siderophore biosysnthesis for
acquisition of iron, which is essential for the bacterial growth
in host (Leoni et al., 2000; Wilson et al., 2001). The above
examples suggest that bacterial virulence factors are regulated
by a complicated regulatory network in response to the adverse
host environment. However, how the regulatory network of
virulence factors interweaves with that of the antibiotic resistance
determinants remains to be studied.
In clinic settings, patients are usually prescribed with
antibiotics after indications of bacterial infections, and as a
result, the invading bacteria encounter antibiotics within the host
milieu. We hypothesized that the global gene expression shaped
by the host environment might influence bacterial resistance
to antibiotics. Here in this study, we compared survival rates
between in vitro grown bacteria and those isolated from mice
and found that the host environment indeed affected bacterial
resistance against antibiotics. To explore the mechanism,
we compared gene expression profiles after treatment with
tobramycin in the presence or absence of epithelial cell line
A549 and differentiated HL60 cells (as neutrophils). Contact
with host cells affected the expression of genes involved in LPS
modification as well as the bacterial membrane potential. Our
results shed light on how host environment affects bacterial
susceptibility to antibiotics.
MATERIALS AND METHODS
Ethics Statement
All animal studies complied with National and Nankai University
guidelines regarding the use of animals in research. All animal
experiments protocol was approved by the institutional animal
care and use committee of the college of life sciences of Nankai
University with the permit number NK-04-2012.
Bacterial Strains and Plasmids
The bacterial strains used in this study are listed in Table S1.
Bacteria were cultured in Luria–Bertani (LB) broth (10 g/l
tryptone, 5 g/l yeast extract, 5 g/l Nacl, pH 7.0–7.5; Oxoid
Ltd, USA) or LB agar (LB broth containing 15 g/l agar) under
aerobic condition at 37◦C. Antibiotics were used at the following
concentrations: for P. aeruginosa, gentamicin at 100 µg/ml,
carbenicillin at 150 µg/ml; for E. coli, ampicillin at 100 µg/ml.
All antibiotics were purchased from BBI life sciences, Shanghai,
China.
Plasmids used in this study are listed in Table S1. For DNA
manipulation, standard protocols or manufacturer’s instructions
of commercial products were followed. A region containing
the waaP gene and 50 bp upstream of the start codon was
amplified by PCR and cloned into the SalI, XbaI sites of
pRKaraRed, resulting in pE2106, where the waaP gene is under
the control of an arabinose-inducible promoter and fused with
a His tag on the C terminus. An IPTG-inducible expression
vector that expresses antisense RNA (asRNA) with paired termini
(PT) against waaP was constructed as previously described
(Nakashima and Tamura, 2009). The fragment of PT and a
transcription terminator T0 (Nakashima and Tamura, 2009)
was synthesized and cloned into the EcoRI-HindIII sites of
pMMB67EH, resulting in pE1992. A fragment covering 35 bp
upstream of the start codon and the first 65 bp of the waaP gene
was PCR amplified and cloned into NcoI-XhoI sites inside of PT
fragment of pE1992, resulting in pP2804.
Cell Culture and HL60 Differentiation
HL60 and A549 cells were cultured in RPMI-1640 medium
with 10% fetal bovine serum (FBS) at 37◦C with 5% CO2,
supplemented with penicillin G (100 U/ml) and streptomycin
(100 µg/ml; Hyclone, USA). HL60 cell differentiation was
performed as previously described (Sun et al., 2014).
In vitro Infection and Bacteria
Susceptibility Assay
A549 cells (1× 104) were seeded into each well of a 96-well plate,
and incubated at 37◦C with 5% CO2 for 16–20 h. The cells were
washed twice with Hank’s balanced salt solution (HBSS; Hyclone,
USA) before bacterial infection. Overnight bacterial culture was
sub-cultured in fresh LB broth and grown to an OD600 of
1.0. Bacteria were washed once and resuspended in HBSS to
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a concentration of 1 × 108 CFU/ml. One hundred microliters
bacterial suspension was added to A549 cells and incubated for
10 min, followed by addition of 1×106 differentiated HL60 cells.
Twenty minutes later, antibiotics at indicated concentrations
were added to each well and incubated at 37◦C. After 50 min,
the number of live bacteria was determined by serial dilution and
plating. The bacterial survival rate was calculated by dividing the
number of live bacteria in the presence of antibiotic by that in the
absence of antibiotic.
Measurement of ROS Level
ROS level was measured as previously described (Sun et al.,
2014) with minor modification. A549 cells in each well of a 96-
well plate were washed twice with warm HBSS. Then, 100 µl
HBSS containing 100 µM luminol and 5 units of horseradish
peroxidase (Sigma) was added to each well. For differentiated
HL60 cells, 1 × 106 cells in 100 µl of HBSS containing 100
µM luminol and 5 units of horseradish peroxidase were added
to each well and incubated for 10 min at 37◦C. PAO1 in HBSS
(1× 107 CFU) were added into each well, and the ROS level was
monitored every 2–5 min for 2 h with a luminometer (Varioskan
Flash, Thermo Scientific).
Reverse Transcription and Real Time PCR
Total RNA was isolated using TRIzol (Thermo Fisher Scientific,
USA) and a Direct-Zol RNA Miniprep (Zymo Research, USA).
Total RNA from cells and bacteria mixtures were immediately
treated with a MICROB Enrich (Life Technologies, USA) kit to
remove RNA from eukaryotic cells. cDNA was synthesized with
PrimeScript Reverse Transcriptase (TaKaRa, Dalian, China) and
random primers. cDNA was mixed with 10 µl SYBR Premix Ex
TaqTM II (TaKaRa) and 4 pmol forward and reverse primers
(Table S1) in a total volume of 20 µl. The 30S ribosomal protein
gene rpsL was used as an internal control in each real time
PCR assay. Real time PCR was performed with a CFX Connect
Real-Time system (Bio-Rad, USA).
RNA Sequencing and Data Analysis
Total RNA was isolated using the Trizol Reagent (Thermo Fisher
Scientific, USA). The quantity and integrity were determined
using a NanoDrop spectrophotometer (Thermo Scientific) and
a Bioanalyzer 2100 system (Agilent). For mRNA sequencing, a
Ribo-Zero rRNA Removal Kit (Illumina, San Diego, CA, USA)
was used to selectively remove rRNA. Random oligonucleotides
and SuperScript III were used to synthesize the first strand cDNA.
Second strand cDNA synthesis was subsequently performed
using DNA Polymerase I and RNase H. Remaining overhangs
were converted into blunt ends via exonuclease/polymerase
treatment. After adenylation of the 3′ ends of the DNA
fragments, Illumina PE adapter oligonucleotides were ligated to
prepare for hybridization. To select cDNA fragments around
300 bp in length, the library fragments were purified using
the AMPure XP system (Beckman Coulter, Beverly, CA, USA).
DNA fragments with ligated adaptor molecules on both ends
were selectively enriched using Illumina PCR Primer Cocktail
in a 15 cycle PCR reaction. The products were purified with
the AMPure XP system and quantified using the Agilent
high sensitivity DNA assay on a Bioanalyzer 2100 system
(Agilent). The DNA library was then sequenced on a NextSeq
500 platform (Illumina) by Shanghai Personal Biotechnology
Cp. Ltd.
Sequence reads were mapped onto PAO1 reference genome
(NC_002516.2) using a CLC genomicsWorkbench 8.0 (CLC Bio-
Qiagen, Aarhus, Denmark). The count data of expression values
were then analyzed using a DESeq package of R/Bioconductor.
The differentially expressed genes were identified by performing
a negative binomial test using the DESeq software, with the
cut-off fold-change larger than 2. The raw sequence reads were
normalized by dividing with size factors, then Log2 (N +
1) transformed. The data have been deposited in the NCBI
Short Read Archive (SRA) database with an accession number
SRP100146.
Membrane Potential Assay
Bacteria with or without incubation with eukaryotic cells were
diluted to 106 CFU/ml inHBSS. Onemicroliter 20mMDiOC2(3)
was incubated with the bacteria in a 1 ml volume and incubated
for 20 min at room temperature in dark, followed by flow
cytometry analyses (Accuri C6, BD). DiOC2(3) was excited at
484 nm and emissions at 530 nm (Green fluorescence) and 610
nm (Red fluorescence) were measured. Membrane potential was
indicated by ratios of Green and Red fluorescence (Novo et al.,
1999).
Down Regulation of waaP by Antisense
RNA
Antisense RNA (AsRNA) construction was performed as
previously described (Nakashima and Tamura, 2009). A fragment
containing 35 bp upstream of the start codon and the first 65 bp
of the waaP gene was amplified using PAO1 genomic DNA as
the template. The fragment was cloned into pE1992, in which
an RNA complementary to the waaP mRNA is driven by an
inducible tac promoter. The construct was confirmed by DNA
sequencing. To examine the inhibitory effect of the AsRNA, the
waaP gene including its upstream 50 bp was fused with a 6×HIS
tag at the 3′ terminus (waaP-His) and cloned into pRKaraRed
(Liang and Liu, 2010; Verstraeten et al., 2015), where expression
of the gene is driven by an arabinose inducible promoter (PBAD).
The two plasmids were co-transformed into PAO1, and the levels
of WaaP-His was determined by Western blot.
Western Blotting
P. aeruginosa strains were grown in LB overnight at 37◦C
and then diluted 50-fold in fresh LB with 1 mM IPTG and
0.2% (vol/vol) arabinose, and cultured for 3 h. Samples from
equivalent numbers of bacterial cells were separated by sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).
The proteins were transferred onto a polyvinylidene difluoride
(PVDF) membrane (Millipore, USA) and probed with a rabbit
polyclonal antibody against 6× HIS (Cell Signaling Technology,
USA). The luminescence signals were detected with an ECL-plus
kit (Millipore, USA).
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In vivo Infection
Mouse acute pneumonia was performed as previously described
(Sun et al., 2014). P. aeruginosa strains were grown in LB
overnight and then subcultured into fresh medium and grown at
37◦C with aeration to an OD600 of 1.0. Bacteria were washed and
adjusted to 2 × 109 CFU/ml in phosphate-buffered saline (PBS).
Each female BALB/c mouse (6–8 weeks old) was anesthetized
with an intraperitoneal injection of 5 µl/g 7.5% chloral hydrate.
Then 20 µl bacterial suspension was intranasally inoculated into
each anesthetized mouse, 10 µl per nostril. Bronchi alveolar
lavage fluid (BALF) was collected as previously described (Wu
et al., 2012). Briefly, 6 h post infection, mice were sacrificed
by inhalation of CO2. Two microliters PBS containing 0.05 mM
EDTA was injected into lungs through trachea by a vein
detained needle (BD, Angiocath). After 1min detaining, fluid was
collected.
RESULTS
Tobramycin Susceptibility of Bacteria
Isolated from BALF
To examine whether host environment affects P. aeruginosa
susceptibility to antibiotics, we infected mice with a wild type
P. aeruginosa strain PAO1 itranasally and isolated bacteria
from BALF 6 h post infection. The bacteria were treated with
tobramycin, which is used in clinic to treat patients infected
by P. aeruginosa. As a comparison, similar numbers of bacteria
grown in LB were treated with tobramycin. The number of
bacteria in each sample was listed in Table S2. Interestingly, the
isolated bacteria showed higher susceptibility to tobramycin than
those grown in vitro (Figure 1), suggesting that host environment
might affect bacterial susceptibility to antibiotics.
Interaction with Differentiated HL60 Cells
Increased Bacterial Susceptibility to
Tobramycin
To explore the mechanism of the increased bacterial
susceptibility, we treated wild type PAO1 with tobramycin in
the presence or absence of mammalian cells in vitro. Previously
in a murine acute pneumonia model, it was demonstrated
that neutrophils are recruited to the lung after infection
with P. aeruginosa (Diaz and Hauser, 2010; Sun et al., 2014).
These results indicate that the invading bacteria contact with
epithelial cells first, followed by encountering neutrophils which
generate reactive oxygen species (ROS) and release proteases
and bactericidal peptides locally (Weiss, 1989). To mimic the
in vivo infection scenario, we infected the human alveolar
adenocarcinoma (A549) cells with PAO1 for 10 min, and then
added neutrophil-like differentiated HL60 cells (designated as
dHL60 hereafter). The response of dHL60 cells to P. aeruginosa
was monitored by measuring ROS production. As shown in
Figure 2A, dHL60 cells generated significantly higher amount
of ROS than A549 cells upon encountering P. aeruginosa.
Meanwhile, live bacteria number was determined 50 min after
the addition of dHL60 cells. As shown in Figure S1, presence
FIGURE 1 | Tobramycin susceptibility of bacteria isolated from BALF.
Survival rate of PAO1 grown in LB or isolated from BALF. Mice were infected
with 4 × 107 PAO1 intranasally. 6 h post infection, bacteria were isolated from
BALF, resuspended in HBSS and treated with 2 µg/ml tobramycin for 50 min.
Bacteria grown in LB were resuspended in HBSS and treated with 2 µg/ml
tobramycin for 50 min. Number of live bacteria was determined by serial
dilution and plating. Error bars represent the standard deviation. ***P < 0.001
by Student’s t-test.
of A549 and dHL60 cells did not affect bacterial survival
(Figure S1).
We next treated PAO1 with 2 µg/ml tobramycin for 10
min followed by the addition of dHL60 cells, when the ROS
production reached the peak (Figure 2A). Fifty minutes later,
the bacterial survival rates were determined (Figure 2B). As
a comparison, similar numbers of bacteria grown in LB were
treated with tobramycin for the same period of time. Compared
to bacteria alone, incubation with A549 and dHL60 cells reduced
the bacterial survival rate by∼80-fold (Figure 2C).
To dissect the role of each type of cell in the increased bacterial
susceptibility, PAO1 were incubated with A549 or dHL60 cells
individually, followed by treatment with tobramycin. A549 cells
did not affect the bacteria survival rate, whereas dHL60 cells
reduced the survival rate by ∼20-fold (Figure 2C). These results
suggest that dHL60 cells play a major role in the increased
bacterial susceptibility to tobramycin, and the presence of A549
cells further increased the bacterial susceptibility.
ROS Contributes to Increased Bacterial
Susceptibility to Tobramycin
As shown in Figure 2, dHL60 cells generate large amount of
ROS upon encountering bacteria. To examine whether ROS
plays a role in sensitizing bacteria to tobramycin, we used 6
N-Acetyl-L-cysteine (NAC) to neutralize ROS (Curtin et al.,
2002). NAC alone did not alter bacterial survival rate in the
absence of dHL60 cells, however, in the presence of dHL60 cells,
NAC increased the survival rate in a dose dependent manner
(Figure 3). To confirm the role of ROS, we treated bacteria with
various concentrations of H2O2 in the presence or absence of
tobramycin. At the concentration of 0.25 mM, H2O2 alone did
not affect bacterial survival, but reduced the survival rate in
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FIGURE 2 | Interaction with host cells increases bacterial susceptibility
to tobramycin. (A) ROS production by A549, dHL-60 or dHL-60 with A549
cells with or without PAO1 infection (MOI = 10). RLU, relative light units. (B)
Schematic diagram of in vitro cell infection and antibiotics treatment assay on
P. aeruginosa. PAO1 cells (1 × 107) were incubated with A549 (4 × 104) for
10 min, followed by addition of 1 × 106 dHL60 cells. After 10 min, 2 µg/ml
tobramycin was added. Then the bacteria and cells were incubated for
another 50 min. The number of live bacteria was determined by serial dilution
and plating. (C) PAO1 alone or PAO1 incubated with indicated cells and
treated with 2 µg/ml tobramycin as illustrated in (B). Same number of bacteria
were used in the survival assay with our without the host cells. The bacterial
survival rate was calculated by dividing the number of live bacteria in the
presence of tobramycin by that incubated with same eukaryotic cells in the
absence of tobramycin. Error bars represent the standard deviation. ***P <
0.001; **P < 0.01 by Student’s t-test.
the presence of tobramycin (Figure S2). These results suggest
that ROS contributes to the increased bacterial susceptibility to
tobramycin.
Transcriptome Analysis of Bacteria
Incubated with Mammalian Cell and/or
Tobramycin
To further explore the mechanism of the increased
bacterial susceptibility to tobramycin, we compared
the transcription profiles among the following samples:
PAO1, PAO1+tobramycin, PAO1+A549+dHL60,
FIGURE 3 | ROS contributes to increased bacterial susceptibility to
tobramycin. PAO1 was incubated with A549 and dHL60 cells and treated
with tobramycin as described in Figure 1. When dHL60 cells were added, 6
N-Acetyl-L-cysteine (NAC) at indicated concentration was also added to the
mixture. The bacterial survival rate was calculated by dividing the number of
live bacteria in the presence of tobramycin by that incubated with same
eukaryotic cells in the absence of tobramycin. Same number of bacteria were
used in the survival assay with our without the host cells. Error bars represent
the standard deviation. ***P < 0.001 by Student’s t-test.
PAO1+A549+dHL60+tobramycin. In a previous transcriptome
analysis of PAO1 in response to tobramycin, bacteria were
treated with 2 µg/ml tobramycin for 30 min in BBL cation-
adjusted Mueller-Hinton broth medium (CAMHB) before RNA
isolation (Kindrachuk et al., 2011). We tested the survival rates
of PAO1 after treatment with 2 µg/ml tobramycin for various
periods of time in HBSS. After 20-min treatment, the bacterial
survival rate was ∼80% (Figure S3A) and we chose this time
point for RNA isolation. Next, we determined the bacterial
survival rates in the presence of A549 and dHL60 cells after
treatment with various concentrations of tobramycin for 20 min.
As shown in Figure S3B, treatment with 0.3 µg/ml tobramycin
resulted in 80% live bacteria. Thus, this condition was chosen
for RNA isolation. To compare the bacterial responses to the
same concentration of tobramycin with or without A549 and
dHL60 cells, we included a bacterial sample treated with 0.3
µg/ml tobramycin for 20 min in HBSS. The experimental
conditions for RNA sample collection are summarized in
Table 1.
The transcriptome analysis results were presented as RNA
expression levels relative to the PAO1 incubated in HBSS
(Table 1, Table S3). Previously, it had been demonstrated
that lethal concentrations of tobramycin highly activated the
expression of genes involved in heat shock response, whereas
bacteriostatic concentrations of tobramycin had minor effect
(Kindrachuk et al., 2011). Consistent with the report, heat shock
response genes ibpA, groES, grpE, hslV, and hslU were all up
regulated after treatment with 2 µg/ml of tobramycin for 20 min
in HBSS, however, 0.3 µg/ml of tobramycin did not significantly
affect the expression of these genes (Table 1). Interestingly,
treatment with 0.3 µg/ml of tobramycin in the presence of A549
and dHL60 cells induced the expression of those heat shock
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genes even higher than treatment by 2 µg/ml of tobramycin in
HBSS (Table 1). Real time PCR analysis confirmed the mRNA
levels of ibpA and groES (Figure 4). These results suggest that
contact with the host cells intensified bacterial response to
tobramycin, which is consistent with our bacterial survival
results.
Contact with dHL60 Decreased Bacterial
Membrane Potential
We hypothesized that the increased bacterial susceptibility to
tobramycin might be due to decreased membrane potential
(Taber et al., 1987). Indeed, incubation with A549 and dHL60
decreased bacterial membrane potential (Figure 5). To dissect
the role of each type of cell in the decreased membrane potential,
we incubated the bacteria with individual cell line. Incubation
with dHL60 but not A549 cells decreased membrane potential
(Figure 5). These results suggest that dHL60 played a major role
in the decreased membrane potential, which might contribute to
increased bacterial susceptibility to tobramycin.
FIGURE 4 | mRNA levels of ibpA and groES during in vitro cell infection.
PAO1 was treated with 0.3 µg/ml of tobramycin for 20 min, followed by RNA
isolation. For treatment with tobramycin in the presence of host cells, PAO1
(1 × 107) was incubated with 4 × 104 A549 cells for 10 min, followed by
addition of 1 × 106 dHL60 cells. After 20 min, 0.3 µg/ml of tobramycin was
added to the mixture and incubated for 20 min, followed by RNA isolation. The
mRNA levels of ibpA and groES were determined by real-time PCR. The 30S
ribosomal protein gene rpsL was used as an internal control. Error bars
represent the standard deviation. **P < 0.01; ***P < 0.001 by Student’s t-test.
Lipopolysaccharide Phosphorylation
Contributes to Increased Bacterial
Susceptibility to Tobramycin
Besides membrane potential, the cellular entry of positively
charged aminoglycoside antibiotic depends on its interaction
with negatively charged LPS (Schindler and Teuber, 1975; Moore
et al., 1986; Schnaitman and Klena, 1993). In our transcriptome
analysis results, we found LPS synthesis genes as well as the
LPS core kinase gene waaP were up regulated in response
to the dHL60 and A549 cells (Table 1). Real time PCR assay
confirmed the results (Figures 6A,B). We thus hypothesized that
the up regulation of the LPS core kinase WaaP might increase
the phosphorylation of LPS, which facilitates the entrance of
tobramycin. Since waaP is an essential gene in P. aeruginosa
(Walsh et al., 2000; Zhao et al., 2002; Delucia et al., 2011), we
overexpressed an antisense RNA to reduce its expression level
(Figure 7A). Indeed, reduction of WaaP level reduced bacterial
susceptibility to tobramycin in the presence of dHL60 and A549
cells (Figure 7B).
If up regulation of WaaP contributes to the increased
bacterial susceptibility to tobramycin, the bacterial should be
susceptible to other aminoglycoside but not a different type
of antibiotics. Indeed, incubation with dHL60 and A549 cells
increased bacterial susceptibility to neomycin, but not the
macrolide antibiotic azithromycin (Figure 7C). Reduction of
WaaP level also reduced bacterial susceptibility to neomycin but
did not affect the susceptibility to azithromycin in the presence of
dHL60 and A549 cells (Figure 7D).
Antibiotic Susceptibility of Bacteria
Isolated from BALF
The in vivo environment is much more complicated than our
in vitro cell infection condition. In addition to epithelial and
phagocytic cells, bacteria encounter a variety of molecules, such
as mucin and defensins as well as iron limiting environment.
In order to investigate whether the host in vivo environment
affects the expression of waaP, we isolated bacteria from BALF
6 h post infection. mRNA levels of the T3SS gene pcrV and
iron acquisition gene hasR, which are known to be activated
during acute pneumonia (Shaver and Hauser, 2004; Damron
et al., 2016) were higher in the bacteria isolated from BALF
(Figure 8A), suggesting an adaptation to host environment.
Consistent with our in vitro cell infection results, the expression
of waaP was induced during infection (Figure 8A). And the
isolated bacteria showed higher susceptibility to neomycin, but
not to azithromycin (Figures 8B,C). Overall, these results suggest
that host environment could affect bacterial susceptibility to
aminoglycoside antibiotics.
DISCUSSION
Host environment imposes various stresses on invading bacteria,
such as bactericidal peptides, complement, minimal free iron,
attack from phagocytes, etc. To survive and replicate, bacteria
produce multiple virulence factors and adjust metabolism. Upon
invasion of host tissues, P. aeruginosa assembles the T3SS on
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FIGURE 5 | Interaction with host cells affects P. aeruginosa membrane
potential. Membrane potential was determined by staining with DiOC2(3).
Samples were prepared as follows: PAO1; PAO1 incubated with A549 cells for
50 min; PAO1 incubated with dHL60 for 40 min; PAO1 incubated with A549
cells for 10 min, followed by addition of dHL60 cells for 40 min. Then cells
were stained with DiOC2(3) for 20 min in dark. The fluorescence was
determined by flow cytometry. Membrane potential was represented by the
ratio between green and red fluorescence. Error bars represent the standard
deviation. **P < 0.01 by Student’s t-test.
the surface, through which effector proteins are directly injected
into and kill host cells, preferentially phagocytes (Mougous et al.,
2006; Diaz and Hauser, 2010). Various iron chelating molecules
and cognate transportation systems are up regulated for the
acquisition of iron from host. Besides, expression of multiple
protein secretion systems and porin proteins are orchestrated and
contribute to bacterial pathogenesis (Bleves et al., 2010; Filloux,
2011). Thus, the membrane permeability and gene expression
profile are significantly altered by host environment.
Membrane permeability is directly related to bacterial
antibiotic resistance (Delcour, 2008). As certain antibiotics
cross outer membrane through specific porins, these proteins
are related to antibiotic resistance. For example, carbapenem
antibiotics enter periplasm through OprD. Mutation in
the oprD gene increases bacterial resistance to carbapenem
antibiotics (Fukuoka et al., 1993). Interestingly, loss of OprD
increases bacterial fitness during infection (Skurnik et al., 2013).
The chromosomally encoded β-lactamase (AmpC) plays an
important role in bacterial resistance to β-lactam antibiotics.
Expression of AmpC is regulated by AmpR in responding
to peptidoglycan integrity stress. Besides, AmpR directly
regulates genes or small RNAs involved in quorum sensing, iron
acquisition, and oxidative stress response (Balasubramanian,
2014). These examples imply that the regulation and functions
of virulence factors and antibiotic resistant determinants are
interwoven together.
During infection, bacteria encounter antibiotic in the in
vivo host environment. The bacterial response to antibiotics in
this special milieu remains largely unknown. In this study, we
examined bacterial susceptibility and response to tobramycin in
the presence of epithelial A549 cells and neutrophil (dHL60) cells,
which represent the major types of cells comes in contact with
FIGURE 6 | mRNA level of waaP and wyz during in vitro cell infection.
RNA samples were prepared as in Figure 3. The mRNA levels of wyz (A) and
waaP (B) were determined by real-time PCR. The 30S ribosomal protein gene
rpsL was used as an internal control. Error bars represent the standard
deviation. ***P < 0.001 by Student’s t-test.
bacteria during infection (Driscoll et al., 2007). Tobramycin is
one of the most frequently used aminoglycoside antibiotics in
the clinic for treatment of P. aeruginosa infections (Gziut et al.,
2013). Aminoglycoside antibiotics bind to negatively charged LPS
by displacing Mg2+ and Ca2+ before penetrating bacteria outer
membrane (Kotra et al., 2001). Here we found that presence of
A549 and dHL60 cells sensitized P. aeruginosa to tobramycin.
One of the causes might be decreased membrane potential as
revealed by flow cytometric analysis (Novo et al., 1999). As
decreased membrane potential indicates increased membrane
permeability (Novo et al., 2000), it is likely that the presence of
host cells lead to higher intracellular antibiotic concentration.
Consistently, in the presence of the host cells, genes known to
response to tobramycin were up regulated by a low concentration
of tobramycin (0.3 µg/ml), which alone could not induce the
expression of these genes.
We further found that ROS generated by neutrophil
contributes to the decreased membrane potential. Previously,
van der Heijden et al. demonstrated that Salmonella regulates
membrane permeability in response to ROS (van der Heijden
et al., 2016). Salmonella outer membrane proteins, OmpA and
OmpC, are rapidly opened or closed in response to oxidative
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 8 March 2017 | Volume 7 | Article 83
Pan et al. Host Cells Affect Antibiotic Susceptibility
FIGURE 7 | Role of the LPS kinase WaaP in the increased bacterial susceptibility to tobramycin. (A) Reduction of WaaP expression by an antisense RNA.
After overnight culturing, PAO1 containing pMMB67EH-waaP (antisense RNA) and pRKaraRed-waaP-His or pMMB67EH and pRKaraRed-waaP-His were
subcultured (1:50) in LB in the presence of indicated concentrations of IPTG and arabinose, and cultured for 3h at 37◦C. The WaaP levels were determined by
Western blotting with an anti-His antibody. (B) Survival rates of PAO1overexpressing antisense RNA against waaP and PAO1 containing the empty vector
pMMB67EH. 1 ×107 of bacteria were incubated with 4 × 104 A549 for 10 min, followed by addition of 1 × 106 differentiated HL60 (dHL60) cells. After 10 min, 2
µg/ml tobramycin was added and incubated for another 50 min. The live bacteria number was determined by serial dilution and plating. The bacterial survival rate was
calculated by dividing the number of live bacteria in the presence of tobramycin by that in the absence of tobramycin. (C) Survival rates of PAO1 alone or incubated
with indicated cells. Bacteria were treated with 2 µg/ml tobramycin, 100 µg/ml neomycin or 300 µg/ml azithromycin. Same number of bacteria were used in the
survival assay with our without the host cells. (D) Survival rates of PAO1 overexpressing antisense RNA against waaP and PAO1 containing the empty vector
pMMB67EH. 1 ×107 of bacteria were incubated with 4 × 104 A549 for 10 min, followed by addition of 1 × 106 differentiated HL60 (dHL60) cells. After 10 min, 100
µg/ml neomycin or 300 µg/ml azithromycin was added and incubated for another 50 min. The bacterial survival rate was calculated by dividing the number of live
bacteria in the presence of antibiotics by that in the absence of tobramycin. Error bars represent the standard deviation. *P < 0.05; **P < 0.01 by Student’s t-test.
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FIGURE 8 | Antibiotic susceptibility of bacteria isolated from BALF. (A)
The mRNA levels of waaP, pcrV, and hasR. RNA was isolated from PAO1
cultured in LB or collected from BALF 6 h post infection. The mRNA levles was
determined by real time PCR. The 30S ribosomal protein gene rpsL was used
as an internal control. ***P < 0.001 by Student’s t-test. (B,C) Survival rate of
PAO1 grown in LB or isolated from BALF. Mice were infected with 4 × 107
PAO1 intranasally. Six hours post infection, bacteria were isolated from BALF,
resuspended in HBSS and treated with 100 µg/ml neomycin (B) or 300 µg/ml
azithromycin (C) for 50 min. Bacteria grown in LB were resuspended in HBSS
and subjected to antibiotic treatments as described for the bacteria isolated
from BALF. Live bacteria number was determined by serial dilution and plating.
Similar numbers of bacteria from BALFs and LB cultures were used in the
assay. The initial CFU of each sample was shown in Table S2. Error bars
represent the standard deviation. *P < 0.05; ns, not significant, by Student’s
t-test.
stresses (van der Heijden et al., 2016). We suspect that ROS
might trigger gene expression alteration, leading to a different
composition of membrane proteins, which affect membrane
permeability. Another possibility is that ROS might impair P.
aeruginosamembrane integrity through damaging phospholipids
or membrane proteins.
Compared to dHL60 alone, preincubation with A549 further
increased bacterial susceptibility to tobramycin (Figure 2C).
It might be possible that the presence of A549 affects the
behavior of dHL60, e.g., the level of degranulation or formation
of neutrophil extracellular traps. In addition, contact with
both A549 and dHL60 cells might further alter bacterial gene
expression compared to dHL60 alone, and thus affects bacterial
susceptibility to antibiotics.
To examine the global gene expression in the presence of
host cells and tobramycin, we performed transcriptome analysis.
No major multidrug eﬄux system was down regulated upon
interaction with A549 and dHL60 cells (Table S3). Interestingly,
we observed that the kinase WaaP which phosphorylates the
LPS inner core were up regulated after interaction with the
cells. The anionic phosphate group is a major source of negative
charge on LPS (Wang and Quinn, 2011; Gyurova et al., 2013).
Aminoglycoside antibiotics are cationic antibiotics. The initial
step of these antibiotics to enter bacterial cell is to bind to
LPS (Rivera et al., 1986). Thus, increased phosphorylation of
LPS might promote binding between aminoglycoside antibiotics
and LPS, which facilitates the entry of the antibiotics. Indeed,
knock-down of WaaP by an antisense RNA partially reduced
the bacterial susceptibility in the presence of host cells. Further
studies are warranted to elucidate the regulatory mechanism of
WaaP as well as its function in bacterial pathogenesis.
Bacteria isolated from BALF in an acute pneumonia model
were more susceptible to tobramycin than in vitro cultured
bacteria. Our results indicated that WaaP was up regulated
during infection, which might contribute to the increased
susceptibility. These results suggest that host in vivo environment
might affect bacterial resistance to antibiotics. However, in the
treatment of chronic P. aeruginosa infection, the killing effect
might be complicated by the formation of biofilm.We aremaking
efforts to study the bacterial susceptibility in biofilm in the
presence of host cells.
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Figure S1 | Effect of host cells on bacterial survival. PAO1 cells (1 × 107)
were incubated with A549 (4 × 104) for 10 min, followed by addition of
differentiated HL60 (dHL60) cells (1 × 106). After 60 min, the number of live
bacteria was determined by serial dilution and plating. Error bars represent the
standard deviation. ∗∗∗P < 0.001 as determined by Student’s t-test.
Figure S2 | H2O2 increases bacterial susceptibility to tobramycin. Survive
rate of PAO1 treated with or without 2 µg/ml tobramycin in the presence of
indicated concentrations of H2O2 for 50 min. Error bars represent the standard
deviation. ∗∗P < 0.01 by Student’s t-test.
Figure S3 | Susceptibility of PAO1 to tobramycin. (A) Survival curve of PAO1
treated with tobramycin at indicated time points. Bacterial cells (1 × 107) were
treated with 2 µg/ml of tobramycin. At indicated time points, the bacterial survival
rates were determined by serial dilution and plating. (B) PAO1 was treated with
tobramycin at indicated concentrations for 20 min. Alternatively, PAO1 was
incubated with A549 (4 × 104) for 10 min, followed by addition of dHL60 cells
(1 × 106). After 20 min, tobramycin at the indicated concentrations was added to
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the mixture and incubated for 20 min. The number of live bacteria was determined
by serial dilution and plating. Error bars represent the standard deviation.
Table S1 | Bacterial strains, plasmids and primers used in this study.
Table S2 | The initial bacterial CFU used in antibiotic treatment assay from
individual BALF or LB culture.
Table S3 | Transcriptome analysis: differentially regulated genes.
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